cyclosporine has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alihemmati, A; Azimi, A; Badalzadeh, R; Yousefi, B | 1 |
1 other study(ies) available for cyclosporine and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury.
Topics: Animals; Apoptosis; Biomarkers; Combined Modality Therapy; Coronary Vessels; Cyclosporine; Cytokines; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Heart; Immunosuppressive Agents; In Vitro Techniques; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Random Allocation; Rats, Wistar; Streptozocin | 2017 |